Similar articles

• [Vitreous hemorrhage: attitudes in therapy, vitrectomy].

  Mathis A, Pagot V, Malecaze F. Mathis A, et al. Diabete Metab. 1993 Sep-Oct;19(5):436-40. Diabete Metab. 1993. PMID: 8056123 Review. French.
• [Management of intra-vitreous hemorrhage in diabetics].

  Baron D, Guiellemant MN, Lignereaux F, Levecq R. Baron D, et al. Oftalmologia. 2002;53(2):76-80. Oftalmologia. 2002. PMID: 12474448 Romanian. No abstract available.
• [Limitation of photocoagulation in diabetic neoproliferative retinopathy as a function of the patients' age].

  Vallat M, Reynaud X, Salomon JL, Lhomme C, Duprat F, Mathon C. Vallat M, et al. Bull Soc Ophtalmol Fr. 1990 Aug-Sep;90(8-9):761-4. Bull Soc Ophtalmol Fr. 1990. PMID: 2257649 Clinical Trial. French. No abstract available.
• [Management of intra-vitreous hemorrhage in diabetes].

  Baron D, Guillemot MN, Lignereux F, Leveque R. Baron D, et al. Oftalmologia. 2002;55(4):70-6. Oftalmologia. 2002. PMID: 12723183 French. No abstract available.
• Management of proliferative diabetic retinopathy.

  Gündüz K, Bakri SJ. Gündüz K, et al. Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.